spacer
home > > spring 2019 > future-proofing the supply chain
PUBLICATIONS


Future-Proofing the Supply Chain

With the regulatory landscape between countries continuing to change and the uncertainty surrounding the changes that Brexit will bring to clinical trial regulations across Europe, it is becoming increasingly important to prepare for changes that might hit the clinical trial supply chain.

With the recent expansion of the clinical trial industry as a result of growing drug innovation and targeted therapies, efforts to tackle ineffectiveness and safety concerns are high on the agenda. From changing import and export regulations to temperature deviation, many challenges will affect the clinical trial supply chain. Planning for these uncertainties, especially in light of prevalent disruptive technologies, now requires more attention than ever.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Simon Jones is the Vice President of Global Products for PRISYM ID, responsible for managing the end-to-end lifecycle of the company product portfolio. He has 20 years of experience in delivering product strategies and product positioning which address market opportunities effectively. Simon is a subject expert in clinical trials labelling, researching this market and discussing industry challenges with PRISYM ID customers and keeping them up-to-date on market trends, regulatory changes, and technology alternatives.
spacer
Simon Jones
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ERT Acquires APDM Wearable Technologies to Reinvent Endpoint Measurement in Clinical Trials

ERT, the global leader in clinical endpoints data collection, today announced the acquisition of APDM Wearable Technologies (APDM, Inc.), a next-generation provider of wearables and digital biomarkers. The combined company will generate higher-fidelity and more powerful data to enable clinical trials to be more predictable, cost-effective, and efficient. Thereby, reinventing endpoint measurement.
More info >>

White Papers

BioT ULT Transporter

BioCision

The growth of biobanking, cell therapy, and complex biopharmaceutical therapies like cancer vaccines has created a strong need for products and processes to ensure the stability of temperature­-sensitive biospecimens. Proper collection, handling, characterization, packaging and shipping of these materials is critical, as poor sample handling impacts researchers working on discovery with patient samples, as well as clinicians treating patients with cutting edge therapies. This white paper describes in detail the BioCision BioT™ ULT Transporter, the first-of-its-kind dry ice-based portable cooling system that maintains a stable -75° to -50°C environment for over 24 hours on one charge of dry ice, enabling reliable handling and transfer of valuable temperature-sensitive biospecimens as part of a larger cold chain standardization process.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement